APO Research
Talk to an analyst

APO RESEARCH · REPORT

Analgesic and Anti-inflammatory API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Analgesic and Anti-inflammatory API Market Analysis and Forecast 2026-2032

1 February 2026213 pages

Choose your research edition.

Industry ResearchAnalgesic and Anti-inflammatory API Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Analgesic and Anti-inflammatory API Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Analgesic and Anti-inflammatory API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Analgesic and Anti-inflammatory API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Analgesic and Anti-inflammatory API Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Analgesic and Anti-inflammatory API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Analgesic and Anti-inflammatory API's global sales reached XX (t) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned IOL as the global sales leader, a title it has maintained for several consecutive years. Notably, IOL's performance in primary markets is also remarkable. In the Chinese market, sales were XX (t), a change of XX% from the previous year. In Europe, sales were XX (t), showing a year-on-year of XX%. In the US, sales were XX (t), a year-on-year change of XX%.

The major global manufacturers in the Analgesic and Anti-inflammatory API market include IOL, Granules India Limited, Mallinckrodt Pharmaceuticals, Novacyl, BASF, Hubei Biocause Group, BBCA Group, Hebei Jiheng Pharmaceutical and Hunan Zhongnan Pharmaceutical, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Analgesic and Anti-inflammatory API production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Analgesic and Anti-inflammatory API by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Analgesic and Anti-inflammatory API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Analgesic and Anti-inflammatory API, also provides the consumption of main regions and countries. Of the upcoming market potential for Analgesic and Anti-inflammatory API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Analgesic and Anti-inflammatory API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Analgesic and Anti-inflammatory API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Analgesic and Anti-inflammatory API sales, projected growth trends, production technology, application and end-user industry.

Analgesic and Anti-inflammatory API Segment by Company

IOL

Granules India Limited

Mallinckrodt Pharmaceuticals

Novacyl

BASF

Hubei Biocause Group

BBCA Group

Hebei Jiheng Pharmaceutical

Hunan Zhongnan Pharmaceutical

Hebei Jingye Medical Technology

Anqiu Lu'an Pharmaceutical

Xinhua Pharm

Zhejiang Kangle Pharmaceutical

Analgesic and Anti-inflammatory API Segment by Type

Dexibuprofen

Diclofenac

Paracetamol

Naproxen

Ibuprofen

Oxaprozin

Aspirin

Others

Analgesic and Anti-inflammatory API Segment by Application

Adults

Children

Analgesic and Anti-inflammatory API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Analgesic and Anti-inflammatory API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Analgesic and Anti-inflammatory API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Analgesic and Anti-inflammatory API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Analgesic and Anti-inflammatory API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Analgesic and Anti-inflammatory API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Analgesic and Anti-inflammatory API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Analgesic and Anti-inflammatory API sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Analgesic and Anti-inflammatory API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dexibuprofen Major Manufacturers Table 3. Diclofenac Major Manufacturers Table 4. Paracetamol Major Manufacturers Table 5. Naproxen Major Manufacturers Table 6. Ibuprofen Major Manufacturers Table 7. Oxaprozin Major Manufacturers Table 8. Aspirin Major Manufacturers Table 9. Others Major Manufacturers Table 10. Global Analgesic and Anti-inflammatory API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 11. Adults Major Manufacturers Table 12. Children Major Manufacturers Table 13. Analgesic and Anti-inflammatory API Industry Trends Table 14. Analgesic and Anti-inflammatory API Industry Drivers Table 15. Analgesic and Anti-inflammatory API Industry Opportunities and Challenges Table 16. Analgesic and Anti-inflammatory API Industry Restraints Table 17. Global Analgesic and Anti-inflammatory API Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 18. Global Analgesic and Anti-inflammatory API Production by Region (2021-2026) & (t) Table 19. Global Analgesic and Anti-inflammatory API Production by Region (2027-2032) & (t) Table 20. Global Analgesic and Anti-inflammatory API Production Market Share by Region (2021-2026) Table 21. Global Analgesic and Anti-inflammatory API Production Market Share by Region (2027-2032) Table 22. Global Analgesic and Anti-inflammatory API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 23. Global Analgesic and Anti-inflammatory API Revenue by Region (2021-2026) & (US$ Million) Table 24. Global Analgesic and Anti-inflammatory API Revenue by Region (2027-2032) & (US$ Million) Table 25. Global Analgesic and Anti-inflammatory API Revenue Market Share by Region (2021-2026) Table 26. Global Analgesic and Anti-inflammatory API Revenue Market Share by Region (2027-2032) Table 27. Global Analgesic and Anti-inflammatory API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 28. Global Analgesic and Anti-inflammatory API Sales by Region (2021-2026) & (t) Table 29. Global Analgesic and Anti-inflammatory API Sales by Region (2027-2032) & (t) Table 30. Global Analgesic and Anti-inflammatory API Sales Market Share by Region (2021-2026) Table 31. Global Analgesic and Anti-inflammatory API Sales Market Share by Region (2027-2032) Table 32. Global Analgesic and Anti-inflammatory API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 33. Global Analgesic and Anti-inflammatory API Revenue Market Share by Manufacturers (2021-2026) Table 34. Global Analgesic and Anti-inflammatory API Sales by Manufacturers (US$ Million) & (2021-2026) Table 35. Global Analgesic and Anti-inflammatory API Sales Market Share by Manufacturers (2021-2026) Table 36. Global Analgesic and Anti-inflammatory API Sales Price (USD/t) of Manufacturers (2021-2026) Table 37. Global Analgesic and Anti-inflammatory API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 38. Global Analgesic and Anti-inflammatory API Key Manufacturers Manufacturing Sites & Headquarters Table 39. Global Analgesic and Anti-inflammatory API Manufacturers, Product Type & Application Table 40. Global Analgesic and Anti-inflammatory API Manufacturers Commercialization Time Table 41. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 42. Global Analgesic and Anti-inflammatory API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 43. Global Analgesic and Anti-inflammatory API Revenue by Type (2021-2026) & (US$ Million) Table 44. Global Analgesic and Anti-inflammatory API Revenue by Type (2027-2032) & (US$ Million) Table 45. Global Analgesic and Anti-inflammatory API Revenue Market Share by Type (2021-2026) Table 46. Global Analgesic and Anti-inflammatory API Revenue Market Share by Type (2027-2032) Table 47. Global Analgesic and Anti-inflammatory API Sales by Type (2021-2026) & (t) Table 48. Global Analgesic and Anti-inflammatory API Sales by Type (2027-2032) & (t) Table 49. Global Analgesic and Anti-inflammatory API Sales Market Share by Type (2021-2026) Table 50. Global Analgesic and Anti-inflammatory API Sales Market Share by Type (2027-2032) Table 51. Global Analgesic and Anti-inflammatory API Price by Type (2021-2026) & (USD/t) Table 52. Global Analgesic and Anti-inflammatory API Price by Type (2027-2032) & (USD/t) Table 53. Global Analgesic and Anti-inflammatory API Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Analgesic and Anti-inflammatory API Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Analgesic and Anti-inflammatory API Revenue Market Share by Application (2021-2026) Table 56. Global Analgesic and Anti-inflammatory API Revenue Market Share by Application (2027-2032) Table 57. Global Analgesic and Anti-inflammatory API Sales by Application (2021-2026) & (t) Table 58. Global Analgesic and Anti-inflammatory API Sales by Application (2027-2032) & (t) Table 59. Global Analgesic and Anti-inflammatory API Sales Market Share by Application (2021-2026) Table 60. Global Analgesic and Anti-inflammatory API Sales Market Share by Application (2027-2032) Table 61. Global Analgesic and Anti-inflammatory API Price by Application (2021-2026) & (USD/t) Table 62. Global Analgesic and Anti-inflammatory API Price by Application (2027-2032) & (USD/t) Table 63. IOL Company Information Table 64. IOL Business Overview Table 65. IOL Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 66. IOL Analgesic and Anti-inflammatory API Product Portfolio Table 67. IOL Recent Development Table 68. Granules India Limited Company Information Table 69. Granules India Limited Business Overview Table 70. Granules India Limited Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. Granules India Limited Analgesic and Anti-inflammatory API Product Portfolio Table 72. Granules India Limited Recent Development Table 73. Mallinckrodt Pharmaceuticals Company Information Table 74. Mallinckrodt Pharmaceuticals Business Overview Table 75. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolio Table 77. Mallinckrodt Pharmaceuticals Recent Development Table 78. Novacyl Company Information Table 79. Novacyl Business Overview Table 80. Novacyl Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Novacyl Analgesic and Anti-inflammatory API Product Portfolio Table 82. Novacyl Recent Development Table 83. BASF Company Information Table 84. BASF Business Overview Table 85. BASF Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. BASF Analgesic and Anti-inflammatory API Product Portfolio Table 87. BASF Recent Development Table 88. Hubei Biocause Group Company Information Table 89. Hubei Biocause Group Business Overview Table 90. Hubei Biocause Group Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolio Table 92. Hubei Biocause Group Recent Development Table 93. BBCA Group Company Information Table 94. BBCA Group Business Overview Table 95. BBCA Group Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. BBCA Group Analgesic and Anti-inflammatory API Product Portfolio Table 97. BBCA Group Recent Development Table 98. Hebei Jiheng Pharmaceutical Company Information Table 99. Hebei Jiheng Pharmaceutical Business Overview Table 100. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio Table 102. Hebei Jiheng Pharmaceutical Recent Development Table 103. Hunan Zhongnan Pharmaceutical Company Information Table 104. Hunan Zhongnan Pharmaceutical Business Overview Table 105. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio Table 107. Hunan Zhongnan Pharmaceutical Recent Development Table 108. Hebei Jingye Medical Technology Company Information Table 109. Hebei Jingye Medical Technology Business Overview Table 110. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolio Table 112. Hebei Jingye Medical Technology Recent Development Table 113. Anqiu Lu'an Pharmaceutical Company Information Table 114. Anqiu Lu'an Pharmaceutical Business Overview Table 115. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 116. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio Table 117. Anqiu Lu'an Pharmaceutical Recent Development Table 118. Xinhua Pharm Company Information Table 119. Xinhua Pharm Business Overview Table 120. Xinhua Pharm Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 121. Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolio Table 122. Xinhua Pharm Recent Development Table 123. Zhejiang Kangle Pharmaceutical Company Information Table 124. Zhejiang Kangle Pharmaceutical Business Overview Table 125. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 126. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio Table 127. Zhejiang Kangle Pharmaceutical Recent Development Table 128. North America Analgesic and Anti-inflammatory API Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Analgesic and Anti-inflammatory API Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Analgesic and Anti-inflammatory API Sales by Type (2021-2026) & (t) Table 131. North America Analgesic and Anti-inflammatory API Sales by Type (2027-2032) & (t) Table 132. North America Analgesic and Anti-inflammatory API Sales Price by Type (2021-2026) & (USD/t) Table 133. North America Analgesic and Anti-inflammatory API Sales Price by Type (2027-2032) & (USD/t) Table 134. North America Analgesic and Anti-inflammatory API Revenue by Application (2021-2026) & (US$ Million) Table 135. North America Analgesic and Anti-inflammatory API Revenue by Application (2027-2032) & (US$ Million) Table 136. North America Analgesic and Anti-inflammatory API Sales by Application (2021-2026) & (t) Table 137. North America Analgesic and Anti-inflammatory API Sales by Application (2027-2032) & (t) Table 138. North America Analgesic and Anti-inflammatory API Sales Price by Application (2021-2026) & (USD/t) Table 139. North America Analgesic and Anti-inflammatory API Sales Price by Application (2027-2032) & (USD/t) Table 140. North America Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. North America Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. North America Analgesic and Anti-inflammatory API Sales by Country (2021 VS 2025 VS 2032) & (t) Table 144. North America Analgesic and Anti-inflammatory API Sales by Country (2021-2026) & (t) Table 145. North America Analgesic and Anti-inflammatory API Sales by Country (2027-2032) & (t) Table 146. North America Analgesic and Anti-inflammatory API Sales Price by Country (2021-2026) & (USD/t) Table 147. North America Analgesic and Anti-inflammatory API Sales Price by Country (2027-2032) & (USD/t) Table 148. United States Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 149. Canada Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 150. Mexico Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 151. Europe Analgesic and Anti-inflammatory API Revenue by Type (2021-2026) & (US$ Million) Table 152. Europe Analgesic and Anti-inflammatory API Revenue by Type (2027-2032) & (US$ Million) Table 153. Europe Analgesic and Anti-inflammatory API Sales by Type (2021-2026) & (t) Table 154. Europe Analgesic and Anti-inflammatory API Sales by Type (2027-2032) & (t) Table 155. Europe Analgesic and Anti-inflammatory API Sales Price by Type (2021-2026) & (USD/t) Table 156. Europe Analgesic and Anti-inflammatory API Sales Price by Type (2027-2032) & (USD/t) Table 157. Europe Analgesic and Anti-inflammatory API Revenue by Application (2021-2026) & (US$ Million) Table 158. Europe Analgesic and Anti-inflammatory API Revenue by Application (2027-2032) & (US$ Million) Table 159. Europe Analgesic and Anti-inflammatory API Sales by Application (2021-2026) & (t) Table 160. Europe Analgesic and Anti-inflammatory API Sales by Application (2027-2032) & (t) Table 161. Europe Analgesic and Anti-inflammatory API Sales Price by Application (2021-2026) & (USD/t) Table 162. Europe Analgesic and Anti-inflammatory API Sales Price by Application (2027-2032) & (USD/t) Table 163. Europe Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Europe Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Europe Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Europe Analgesic and Anti-inflammatory API Sales by Country (2021 VS 2025 VS 2032) & (t) Table 167. Europe Analgesic and Anti-inflammatory API Sales by Country (2021-2026) & (t) Table 168. Europe Analgesic and Anti-inflammatory API Sales by Country (2027-2032) & (t) Table 169. Europe Analgesic and Anti-inflammatory API Sales Price by Country (2021-2026) & (USD/t) Table 170. Europe Analgesic and Anti-inflammatory API Sales Price by Country (2027-2032) & (USD/t) Table 171. Germany Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 172. France Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 173. U.K. Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 174. Italy Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 175. Russia Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 176. Spain Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 177. Netherlands Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 178. Switzerland Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 179. Sweden Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 180. Poland Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 181. China Analgesic and Anti-inflammatory API Revenue by Type (2021-2026) & (US$ Million) Table 182. China Analgesic and Anti-inflammatory API Revenue by Type (2027-2032) & (US$ Million) Table 183. China Analgesic and Anti-inflammatory API Sales by Type (2021-2026) & (t) Table 184. China Analgesic and Anti-inflammatory API Sales by Type (2027-2032) & (t) Table 185. China Analgesic and Anti-inflammatory API Sales Price by Type (2021-2026) & (USD/t) Table 186. China Analgesic and Anti-inflammatory API Sales Price by Type (2027-2032) & (USD/t) Table 187. China Analgesic and Anti-inflammatory API Revenue by Application (2021-2026) & (US$ Million) Table 188. China Analgesic and Anti-inflammatory API Revenue by Application (2027-2032) & (US$ Million) Table 189. China Analgesic and Anti-inflammatory API Sales by Application (2021-2026) & (t) Table 190. China Analgesic and Anti-inflammatory API Sales by Application (2027-2032) & (t) Table 191. China Analgesic and Anti-inflammatory API Sales Price by Application (2021-2026) & (USD/t) Table 192. China Analgesic and Anti-inflammatory API Sales Price by Application (2027-2032) & (USD/t) Table 193. Asia Analgesic and Anti-inflammatory API Revenue by Type (2021-2026) & (US$ Million) Table 194. Asia Analgesic and Anti-inflammatory API Revenue by Type (2027-2032) & (US$ Million) Table 195. Asia Analgesic and Anti-inflammatory API Sales by Type (2021-2026) & (t) Table 196. Asia Analgesic and Anti-inflammatory API Sales by Type (2027-2032) & (t) Table 197. Asia Analgesic and Anti-inflammatory API Sales Price by Type (2021-2026) & (USD/t) Table 198. Asia Analgesic and Anti-inflammatory API Sales Price by Type (2027-2032) & (USD/t) Table 199. Asia Analgesic and Anti-inflammatory API Revenue by Application (2021-2026) & (US$ Million) Table 200. Asia Analgesic and Anti-inflammatory API Revenue by Application (2027-2032) & (US$ Million) Table 201. Asia Analgesic and Anti-inflammatory API Sales by Application (2021-2026) & (t) Table 202. Asia Analgesic and Anti-inflammatory API Sales by Application (2027-2032) & (t) Table 203. Asia Analgesic and Anti-inflammatory API Sales Price by Application (2021-2026) & (USD/t) Table 204. Asia Analgesic and Anti-inflammatory API Sales Price by Application (2027-2032) & (USD/t) Table 205. Asia Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. Asia Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. Asia Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. Asia Analgesic and Anti-inflammatory API Sales by Country (2021 VS 2025 VS 2032) & (t) Table 209. Asia Analgesic and Anti-inflammatory API Sales by Country (2021-2026) & (t) Table 210. Asia Analgesic and Anti-inflammatory API Sales by Country (2027-2032) & (t) Table 211. Asia Analgesic and Anti-inflammatory API Sales Price by Country (2021-2026) & (USD/t) Table 212. Asia Analgesic and Anti-inflammatory API Sales Price by Country (2027-2032) & (USD/t) Table 213. Japan Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 214. South Korea Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 215. India Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 216. Australia Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 217. Taiwan Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 218. Southeast Asia Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 219. SAMEA Analgesic and Anti-inflammatory API Revenue by Type (2021-2026) & (US$ Million) Table 220. SAMEA Analgesic and Anti-inflammatory API Revenue by Type (2027-2032) & (US$ Million) Table 221. SAMEA Analgesic and Anti-inflammatory API Sales by Type (2021-2026) & (t) Table 222. SAMEA Analgesic and Anti-inflammatory API Sales by Type (2027-2032) & (t) Table 223. SAMEA Analgesic and Anti-inflammatory API Sales Price by Type (2021-2026) & (USD/t) Table 224. SAMEA Analgesic and Anti-inflammatory API Sales Price by Type (2027-2032) & (USD/t) Table 225. SAMEA Analgesic and Anti-inflammatory API Revenue by Application (2021-2026) & (US$ Million) Table 226. SAMEA Analgesic and Anti-inflammatory API Revenue by Application (2027-2032) & (US$ Million) Table 227. SAMEA Analgesic and Anti-inflammatory API Sales by Application (2021-2026) & (t) Table 228. SAMEA Analgesic and Anti-inflammatory API Sales by Application (2027-2032) & (t) Table 229. SAMEA Analgesic and Anti-inflammatory API Sales Price by Application (2021-2026) & (USD/t) Table 230. SAMEA Analgesic and Anti-inflammatory API Sales Price by Application (2027-2032) & (USD/t) Table 231. SAMEA Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. SAMEA Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. SAMEA Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. SAMEA Analgesic and Anti-inflammatory API Sales by Country (2021 VS 2025 VS 2032) & (t) Table 235. SAMEA Analgesic and Anti-inflammatory API Sales by Country (2021-2026) & (t) Table 236. SAMEA Analgesic and Anti-inflammatory API Sales by Country (2027-2032) & (t) Table 237. SAMEA Analgesic and Anti-inflammatory API Sales Price by Country (2021-2026) & (USD/t) Table 238. SAMEA Analgesic and Anti-inflammatory API Sales Price by Country (2027-2032) & (USD/t) Table 239. Brazil Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 240. Argentina Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 241. Chile Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 242. Colombia Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 243. Peru Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 244. Saudi Arabia Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 245. Israel Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 246. UAE Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 247. Turkey Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 248. Iran Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 249. Egypt Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Table 250. Key Raw Materials Table 251. Raw Materials Key Suppliers Table 252. Analgesic and Anti-inflammatory API Distributors List Table 253. Analgesic and Anti-inflammatory API Customers List Table 254. Research Programs/Design for This Report Table 255. Authors List of This Report Table 256. Secondary Sources Table 257. Primary Sources List of Figures Figure 1. Analgesic and Anti-inflammatory API Product Image Figure 2. Global Analgesic and Anti-inflammatory API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Analgesic and Anti-inflammatory API Market Size Share 2021 VS 2025 VS 2032 Figure . Dexibuprofen Image Figure 1. Diclofenac Image Figure 2. Paracetamol Image Figure 3. Naproxen Image Figure 4. Ibuprofen Image Figure 5. Oxaprozin Image Figure 6. Aspirin Image Figure 7. Others Image Figure 8. Global Analgesic and Anti-inflammatory API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Analgesic and Anti-inflammatory API Market Size Share 2021 VS 2025 VS 2032 Figure 10. Adults Image Figure 11. Children Image Figure 12. Global Analgesic and Anti-inflammatory API Capacity, Capacity Utilization (2021-2032) & (t) Figure 13. Global Analgesic and Anti-inflammatory API Production by Region: 2021 VS 2025 VS 2032 (t) Figure 14. Global Analgesic and Anti-inflammatory API Production Market Share by Region: 2025 Versus 2032 Figure 15. Global Analgesic and Anti-inflammatory API Production Market Share by Region (2021-2032) Figure 16. North America Analgesic and Anti-inflammatory API Production Growth Rate (2021-2032) & (t) Figure 17. Europe Analgesic and Anti-inflammatory API Production Growth Rate (2021-2032) & (t) Figure 18. China Analgesic and Anti-inflammatory API Production Growth Rate (2021-2032) & (t) Figure 19. Japan Analgesic and Anti-inflammatory API Production Growth Rate (2021-2032) & (t) Figure 20. Global Analgesic and Anti-inflammatory API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Analgesic and Anti-inflammatory API Revenue (2021-2032) & (US$ Million) Figure 22. Global Analgesic and Anti-inflammatory API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Analgesic and Anti-inflammatory API Revenue Market Share by Region: 2025 Versus 2032 Figure 24. Global Analgesic and Anti-inflammatory API Revenue Market Share by Region (2021-2032) Figure 25. Global Analgesic and Anti-inflammatory API Sales (2021-2032) & (t) Figure 26. Global Analgesic and Anti-inflammatory API Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 27. Global Analgesic and Anti-inflammatory API Sales Market Share by Region (2021-2032) Figure 28. North America Analgesic and Anti-inflammatory API Sales YoY (2021-2032) & (t) Figure 29. Europe Analgesic and Anti-inflammatory API Sales YoY (2021-2032) & (t) Figure 30. China Analgesic and Anti-inflammatory API Sales YoY (2021-2032) & (t) Figure 31. Asia (Excluding China) Analgesic and Anti-inflammatory API Sales YoY (2021-2032) & (t) Figure 32. South America, Middle East and Africa Analgesic and Anti-inflammatory API Sales YoY (2021-2032) & (t) Figure 33. Global Analgesic and Anti-inflammatory API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 34. Global Analgesic and Anti-inflammatory API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 35. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. Global Analgesic and Anti-inflammatory API Revenue Market Share by Type (2021-2032) Figure 37. Global Analgesic and Anti-inflammatory API Sales Market Share by Type (2021-2032) Figure 38. Global Analgesic and Anti-inflammatory API Revenue Market Share by Application (2021-2032) Figure 39. Global Analgesic and Anti-inflammatory API Sales Market Share by Application (2021-2032) Figure 40. North America Analgesic and Anti-inflammatory API Revenue Share by Type (2021-2032) Figure 41. North America Analgesic and Anti-inflammatory API Sales Share by Type (2021-2032) Figure 42. North America Analgesic and Anti-inflammatory API Revenue Share by Application (2021-2032) Figure 43. North America Analgesic and Anti-inflammatory API Sales Share by Application (2021-2032) Figure 44. North America Analgesic and Anti-inflammatory API Revenue Share by Country (2021-2032) Figure 45. North America Analgesic and Anti-inflammatory API Sales Share by Country (2021-2032) Figure 46. Europe Analgesic and Anti-inflammatory API Revenue Share by Type (2021-2032) Figure 47. Europe Analgesic and Anti-inflammatory API Sales Share by Type (2021-2032) Figure 48. Europe Analgesic and Anti-inflammatory API Revenue Share by Application (2021-2032) Figure 49. Europe Analgesic and Anti-inflammatory API Sales Share by Application (2021-2032) Figure 50. Europe Analgesic and Anti-inflammatory API Revenue Share by Country (2021-2032) Figure 51. Europe Analgesic and Anti-inflammatory API Sales Share by Country (2021-2032) Figure 52. China Analgesic and Anti-inflammatory API Revenue Share by Type (2021-2032) Figure 53. China Analgesic and Anti-inflammatory API Sales Share by Type (2021-2032) Figure 54. China Analgesic and Anti-inflammatory API Revenue Share by Application (2021-2032) Figure 55. China Analgesic and Anti-inflammatory API Sales Share by Application (2021-2032) Figure 56. Asia Analgesic and Anti-inflammatory API Revenue Share by Type (2021-2032) Figure 57. Asia Analgesic and Anti-inflammatory API Sales Share by Type (2021-2032) Figure 58. Asia Analgesic and Anti-inflammatory API Revenue Share by Application (2021-2032) Figure 59. Asia Analgesic and Anti-inflammatory API Sales Share by Application (2021-2032) Figure 60. Asia Analgesic and Anti-inflammatory API Revenue Share by Country (2021-2032) Figure 61. Asia Analgesic and Anti-inflammatory API Sales Share by Country (2021-2032) Figure 62. SAMEA Analgesic and Anti-inflammatory API Revenue Share by Type (2021-2032) Figure 63. SAMEA Analgesic and Anti-inflammatory API Sales Share by Type (2021-2032) Figure 64. SAMEA Analgesic and Anti-inflammatory API Revenue Share by Application (2021-2032) Figure 65. SAMEA Analgesic and Anti-inflammatory API Sales Share by Application (2021-2032) Figure 66. SAMEA Analgesic and Anti-inflammatory API Revenue Share by Country (2021-2032) Figure 67. SAMEA Analgesic and Anti-inflammatory API Sales Share by Country (2021-2032) Figure 68. Analgesic and Anti-inflammatory API Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Analgesic and Anti-inflammatory API Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Dexibuprofen
  • Diclofenac
  • Paracetamol
  • Naproxen
  • Ibuprofen
  • Oxaprozin
  • Aspirin
  • Others
Applications
  • Adults
  • Children
Companies covered
  • IOL
  • Granules India Limited
  • Mallinckrodt Pharmaceuticals
  • Novacyl
  • BASF
  • Hubei Biocause Group
  • BBCA Group
  • Hebei Jiheng Pharmaceutical
  • Hunan Zhongnan Pharmaceutical
  • Hebei Jingye Medical Technology
  • Anqiu Lu'an Pharmaceutical
  • Xinhua Pharm
  • Zhejiang Kangle Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Analgesic and Anti-inflammatory API Market by Type
  3. 1.2.1 Global Analgesic and Anti-inflammatory API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dexibuprofen
  5. 1.2.3 Diclofenac
  6. 1.2.4 Paracetamol
  7. 1.2.5 Naproxen
  8. 1.2.6 Ibuprofen
  9. 1.2.7 Oxaprozin
  10. 1.2.8 Aspirin
  11. 1.2.9 Others
  12. 1.3 Analgesic and Anti-inflammatory API Market by Application
  13. 1.3.1 Global Analgesic and Anti-inflammatory API Market Size by Application, 2021 VS 2025 VS 2032
  14. 1.3.2 Adults
  15. 1.3.3 Children
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Analgesic and Anti-inflammatory API Market Dynamics
  1. 2.1 Analgesic and Anti-inflammatory API Industry Trends
  2. 2.2 Analgesic and Anti-inflammatory API Industry Drivers
  3. 2.3 Analgesic and Anti-inflammatory API Industry Opportunities and Challenges
  4. 2.4 Analgesic and Anti-inflammatory API Industry Restraints
3 Global Analgesic and Anti-inflammatory API Production Overview
  1. 3.1 Global Analgesic and Anti-inflammatory API Production Capacity (2021-2032)
  2. 3.2 Global Analgesic and Anti-inflammatory API Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Analgesic and Anti-inflammatory API Production by Region
  4. 3.3.1 Global Analgesic and Anti-inflammatory API Production by Region (2021-2026)
  5. 3.3.2 Global Analgesic and Anti-inflammatory API Production by Region (2027-2032)
  6. 3.3.3 Global Analgesic and Anti-inflammatory API Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Analgesic and Anti-inflammatory API Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Analgesic and Anti-inflammatory API Revenue by Region
  3. 4.2.1 Global Analgesic and Anti-inflammatory API Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Analgesic and Anti-inflammatory API Revenue by Region (2021-2026)
  5. 4.2.3 Global Analgesic and Anti-inflammatory API Revenue by Region (2027-2032)
  6. 4.2.4 Global Analgesic and Anti-inflammatory API Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Analgesic and Anti-inflammatory API Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Analgesic and Anti-inflammatory API Sales by Region
  9. 4.4.1 Global Analgesic and Anti-inflammatory API Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Analgesic and Anti-inflammatory API Sales by Region (2021-2026)
  11. 4.4.3 Global Analgesic and Anti-inflammatory API Sales by Region (2027-2032)
  12. 4.4.4 Global Analgesic and Anti-inflammatory API Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Analgesic and Anti-inflammatory API Revenue by Manufacturers
  2. 5.1.1 Global Analgesic and Anti-inflammatory API Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Analgesic and Anti-inflammatory API Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Analgesic and Anti-inflammatory API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Analgesic and Anti-inflammatory API Sales by Manufacturers
  6. 5.2.1 Global Analgesic and Anti-inflammatory API Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Analgesic and Anti-inflammatory API Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Analgesic and Anti-inflammatory API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Analgesic and Anti-inflammatory API Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Analgesic and Anti-inflammatory API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Analgesic and Anti-inflammatory API Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Analgesic and Anti-inflammatory API Manufacturers, Product Type & Application
  13. 5.7 Global Analgesic and Anti-inflammatory API Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Analgesic and Anti-inflammatory API Market CR5 and HHI
  16. 5.8.2 2025 Analgesic and Anti-inflammatory API Tier 1, Tier 2, and Tier 3
6 Analgesic and Anti-inflammatory API Market by Type
  1. 6.1 Global Analgesic and Anti-inflammatory API Revenue by Type
  2. 6.1.1 Global Analgesic and Anti-inflammatory API Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Analgesic and Anti-inflammatory API Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Analgesic and Anti-inflammatory API Sales by Type
  5. 6.2.1 Global Analgesic and Anti-inflammatory API Sales by Type (2021-2032) & (t)
  6. 6.2.2 Global Analgesic and Anti-inflammatory API Sales Market Share by Type (2021-2032)
  7. 6.3 Global Analgesic and Anti-inflammatory API Price by Type
7 Analgesic and Anti-inflammatory API Market by Application
  1. 7.1 Global Analgesic and Anti-inflammatory API Revenue by Application
  2. 7.1.1 Global Analgesic and Anti-inflammatory API Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Analgesic and Anti-inflammatory API Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Analgesic and Anti-inflammatory API Sales by Application
  5. 7.2.1 Global Analgesic and Anti-inflammatory API Sales by Application (2021-2032) & (t)
  6. 7.2.2 Global Analgesic and Anti-inflammatory API Sales Market Share by Application (2021-2032)
  7. 7.3 Global Analgesic and Anti-inflammatory API Price by Application
8 Company Profiles
  1. 8.1 IOL
  2. 8.1.1 IOL Company Information
  3. 8.1.2 IOL Business Overview
  4. 8.1.3 IOL Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 IOL Analgesic and Anti-inflammatory API Product Portfolio
  6. 8.1.5 IOL Recent Developments
  7. 8.2 Granules India Limited
  8. 8.2.1 Granules India Limited Company Information
  9. 8.2.2 Granules India Limited Business Overview
  10. 8.2.3 Granules India Limited Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Granules India Limited Analgesic and Anti-inflammatory API Product Portfolio
  12. 8.2.5 Granules India Limited Recent Developments
  13. 8.3 Mallinckrodt Pharmaceuticals
  14. 8.3.1 Mallinckrodt Pharmaceuticals Company Information
  15. 8.3.2 Mallinckrodt Pharmaceuticals Business Overview
  16. 8.3.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolio
  18. 8.3.5 Mallinckrodt Pharmaceuticals Recent Developments
  19. 8.4 Novacyl
  20. 8.4.1 Novacyl Company Information
  21. 8.4.2 Novacyl Business Overview
  22. 8.4.3 Novacyl Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Novacyl Analgesic and Anti-inflammatory API Product Portfolio
  24. 8.4.5 Novacyl Recent Developments
  25. 8.5 BASF
  26. 8.5.1 BASF Company Information
  27. 8.5.2 BASF Business Overview
  28. 8.5.3 BASF Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 BASF Analgesic and Anti-inflammatory API Product Portfolio
  30. 8.5.5 BASF Recent Developments
  31. 8.6 Hubei Biocause Group
  32. 8.6.1 Hubei Biocause Group Company Information
  33. 8.6.2 Hubei Biocause Group Business Overview
  34. 8.6.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolio
  36. 8.6.5 Hubei Biocause Group Recent Developments
  37. 8.7 BBCA Group
  38. 8.7.1 BBCA Group Company Information
  39. 8.7.2 BBCA Group Business Overview
  40. 8.7.3 BBCA Group Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 BBCA Group Analgesic and Anti-inflammatory API Product Portfolio
  42. 8.7.5 BBCA Group Recent Developments
  43. 8.8 Hebei Jiheng Pharmaceutical
  44. 8.8.1 Hebei Jiheng Pharmaceutical Company Information
  45. 8.8.2 Hebei Jiheng Pharmaceutical Business Overview
  46. 8.8.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
  48. 8.8.5 Hebei Jiheng Pharmaceutical Recent Developments
  49. 8.9 Hunan Zhongnan Pharmaceutical
  50. 8.9.1 Hunan Zhongnan Pharmaceutical Company Information
  51. 8.9.2 Hunan Zhongnan Pharmaceutical Business Overview
  52. 8.9.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
  54. 8.9.5 Hunan Zhongnan Pharmaceutical Recent Developments
  55. 8.10 Hebei Jingye Medical Technology
  56. 8.10.1 Hebei Jingye Medical Technology Company Information
  57. 8.10.2 Hebei Jingye Medical Technology Business Overview
  58. 8.10.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolio
  60. 8.10.5 Hebei Jingye Medical Technology Recent Developments
  61. 8.11 Anqiu Lu'an Pharmaceutical
  62. 8.11.1 Anqiu Lu'an Pharmaceutical Company Information
  63. 8.11.2 Anqiu Lu'an Pharmaceutical Business Overview
  64. 8.11.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
  66. 8.11.5 Anqiu Lu'an Pharmaceutical Recent Developments
  67. 8.12 Xinhua Pharm
  68. 8.12.1 Xinhua Pharm Company Information
  69. 8.12.2 Xinhua Pharm Business Overview
  70. 8.12.3 Xinhua Pharm Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolio
  72. 8.12.5 Xinhua Pharm Recent Developments
  73. 8.13 Zhejiang Kangle Pharmaceutical
  74. 8.13.1 Zhejiang Kangle Pharmaceutical Company Information
  75. 8.13.2 Zhejiang Kangle Pharmaceutical Business Overview
  76. 8.13.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
  78. 8.13.5 Zhejiang Kangle Pharmaceutical Recent Developments
9 North America
  1. 9.1 North America Analgesic and Anti-inflammatory API Market Size by Type
  2. 9.1.1 North America Analgesic and Anti-inflammatory API Revenue by Type (2021-2032)
  3. 9.1.2 North America Analgesic and Anti-inflammatory API Sales by Type (2021-2032)
  4. 9.1.3 North America Analgesic and Anti-inflammatory API Price by Type (2021-2032)
  5. 9.2 North America Analgesic and Anti-inflammatory API Market Size by Application
  6. 9.2.1 North America Analgesic and Anti-inflammatory API Revenue by Application (2021-2032)
  7. 9.2.2 North America Analgesic and Anti-inflammatory API Sales by Application (2021-2032)
  8. 9.2.3 North America Analgesic and Anti-inflammatory API Price by Application (2021-2032)
  9. 9.3 North America Analgesic and Anti-inflammatory API Market Size by Country
  10. 9.3.1 North America Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Analgesic and Anti-inflammatory API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Analgesic and Anti-inflammatory API Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Analgesic and Anti-inflammatory API Market Size by Type
  2. 10.1.1 Europe Analgesic and Anti-inflammatory API Revenue by Type (2021-2032)
  3. 10.1.2 Europe Analgesic and Anti-inflammatory API Sales by Type (2021-2032)
  4. 10.1.3 Europe Analgesic and Anti-inflammatory API Price by Type (2021-2032)
  5. 10.2 Europe Analgesic and Anti-inflammatory API Market Size by Application
  6. 10.2.1 Europe Analgesic and Anti-inflammatory API Revenue by Application (2021-2032)
  7. 10.2.2 Europe Analgesic and Anti-inflammatory API Sales by Application (2021-2032)
  8. 10.2.3 Europe Analgesic and Anti-inflammatory API Price by Application (2021-2032)
  9. 10.3 Europe Analgesic and Anti-inflammatory API Market Size by Country
  10. 10.3.1 Europe Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Analgesic and Anti-inflammatory API Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Analgesic and Anti-inflammatory API Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Analgesic and Anti-inflammatory API Market Size by Type
  2. 11.1.1 China Analgesic and Anti-inflammatory API Revenue by Type (2021-2032)
  3. 11.1.2 China Analgesic and Anti-inflammatory API Sales by Type (2021-2032)
  4. 11.1.3 China Analgesic and Anti-inflammatory API Price by Type (2021-2032)
  5. 11.2 China Analgesic and Anti-inflammatory API Market Size by Application
  6. 11.2.1 China Analgesic and Anti-inflammatory API Revenue by Application (2021-2032)
  7. 11.2.2 China Analgesic and Anti-inflammatory API Sales by Application (2021-2032)
  8. 11.2.3 China Analgesic and Anti-inflammatory API Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Analgesic and Anti-inflammatory API Market Size by Type
  2. 12.1.1 Asia Analgesic and Anti-inflammatory API Revenue by Type (2021-2032)
  3. 12.1.2 Asia Analgesic and Anti-inflammatory API Sales by Type (2021-2032)
  4. 12.1.3 Asia Analgesic and Anti-inflammatory API Price by Type (2021-2032)
  5. 12.2 Asia Analgesic and Anti-inflammatory API Market Size by Application
  6. 12.2.1 Asia Analgesic and Anti-inflammatory API Revenue by Application (2021-2032)
  7. 12.2.2 Asia Analgesic and Anti-inflammatory API Sales by Application (2021-2032)
  8. 12.2.3 Asia Analgesic and Anti-inflammatory API Price by Application (2021-2032)
  9. 12.3 Asia Analgesic and Anti-inflammatory API Market Size by Country
  10. 12.3.1 Asia Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Analgesic and Anti-inflammatory API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Analgesic and Anti-inflammatory API Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Analgesic and Anti-inflammatory API Market Size by Type
  2. 13.1.1 SAMEA Analgesic and Anti-inflammatory API Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Analgesic and Anti-inflammatory API Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Analgesic and Anti-inflammatory API Price by Type (2021-2032)
  5. 13.2 SAMEA Analgesic and Anti-inflammatory API Market Size by Application
  6. 13.2.1 SAMEA Analgesic and Anti-inflammatory API Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Analgesic and Anti-inflammatory API Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Analgesic and Anti-inflammatory API Price by Application (2021-2032)
  9. 13.3 SAMEA Analgesic and Anti-inflammatory API Market Size by Country
  10. 13.3.1 SAMEA Analgesic and Anti-inflammatory API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Analgesic and Anti-inflammatory API Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Analgesic and Anti-inflammatory API Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Analgesic and Anti-inflammatory API Value Chain Analysis
  2. 14.1.1 Analgesic and Anti-inflammatory API Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Analgesic and Anti-inflammatory API Production Mode & Process
  6. 14.2 Analgesic and Anti-inflammatory API Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Analgesic and Anti-inflammatory API Distributors
  9. 14.2.3 Analgesic and Anti-inflammatory API Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst